S0337, Gemcitabine After Surgery in Treating Patients With Newly Diagnosed or Recurrent Bladder Cancer

NCT00445601 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

406

Enrollment

NETWORK

Sponsor class

Conditions

Bladder Cancer

Interventions

DRUG: gemcitabine hydrochloride
OTHER: placebo

Sponsor

SWOG Cancer Research Network

Collaborators

[object Object]